Rankings
▼
Calendar
FATE Q4 2021 Earnings — Fate Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FATE
Fate Therapeutics, Inc.
$158M
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$17M
+7.4% YoY
Gross Profit
-$52M
-307.3% margin
Operating Income
-$69M
-406.5% margin
Net Income
-$69M
-402.0% margin
EPS (Diluted)
$-0.72
QoQ Revenue Growth
+20.0%
Cash Flow
Operating Cash Flow
-$70M
Free Cash Flow
-$89M
Stock-Based Comp.
$15M
Balance Sheet
Total Assets
$921M
Total Liabilities
$243M
Stockholders' Equity
$679M
Cash & Equivalents
$134M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$17M
$16M
+7.4%
Gross Profit
-$52M
-$23M
-127.2%
Operating Income
-$69M
-$33M
-107.7%
Net Income
-$69M
-$53M
-29.2%
← FY 2021
All Quarters
Q1 2022 →